Skip to content

Insider · CIK 0001235470

STARR CHRISTOPHER M

Reports to the SEC for 4 companies · WILMETTE, IL

Transactions

50

Companies

4

Filings

9

CIK

0001235470

Forms 4 and 5

Insider transactions

50 trades
DateCompanyValue
2026-10-01MNPRMonopar TherapeuticsS Sale−$234K
2026-10-01MNPRMonopar Therapeutics · Stock OptionM Exercise/Conversion—
2026-10-01MNPRMonopar TherapeuticsS Sale−$63.7K
2026-10-01MNPRMonopar TherapeuticsM Exercise/Conversion+$42
2026-10-01MNPRMonopar TherapeuticsS Sale−$362K
2025-12-02MNPRMonopar Therapeutics · Stock OptionsA Award—
2025-07-14MNPRMonopar TherapeuticsS Sale−$672K
2025-07-14MNPRMonopar TherapeuticsX Exercise of In-Money+$84
2025-07-14MNPRMonopar Therapeutics · Stock OptionsX Exercise of In-Money—
2025-03-04MNPRMonopar Therapeutics · Stock OptionsA Award—
2023-12-31MNPRMonopar Therapeutics · Restricted Stock UnitsM Exercise/Conversion—
2023-12-31MNPRMonopar TherapeuticsM Exercise/Conversion—
2023-09-30MNPRMonopar TherapeuticsM Exercise/Conversion—
2023-09-30MNPRMonopar Therapeutics · Restricted Stock UnitsM Exercise/Conversion—
2023-06-30MNPRMonopar TherapeuticsM Exercise/Conversion—
2023-06-30MNPRMonopar Therapeutics · Restricted Stock UnitsM Exercise/Conversion—
2023-03-31MNPRMonopar Therapeutics · Restricted Stock UnitsM Exercise/Conversion—
2023-03-31MNPRMonopar TherapeuticsM Exercise/Conversion—
2023-02-01MNPRMonopar Therapeutics · Stock OptionsA Award—
2023-02-01MNPRMonopar Therapeutics · Restricted Stock UnitsA Award—
2022-12-31MNPRMonopar TherapeuticsM Exercise/Conversion—
2022-12-31MNPRMonopar Therapeutics · Restricted Stock UnitsM Exercise/Conversion—
2022-09-30MNPRMonopar TherapeuticsM Exercise/Conversion—
2022-09-30MNPRMonopar Therapeutics · Restricted Stock UnitsM Exercise/Conversion—
2022-06-30MNPRMonopar Therapeutics · Restricted Stock UnitsM Exercise/Conversion—
2022-06-30MNPRMonopar TherapeuticsM Exercise/Conversion—
2022-03-31MNPRMonopar Therapeutics · Restricted Stock UnitsM Exercise/Conversion—
2022-03-31MNPRMonopar TherapeuticsM Exercise/Conversion—
2022-02-02MNPRMonopar Therapeutics · Restricted Stock OptionsA Award—
2022-02-02MNPRMonopar Therapeutics · Stock OptionsA Award—
2021-12-31MNPRMonopar Therapeutics · Restricted Stock UnitsM Exercise/Conversion—
2021-12-31MNPRMonopar TherapeuticsM Exercise/Conversion—
2021-09-30MNPRMonopar Therapeutics · Restricted Stock UnitsM Exercise/Conversion—
2021-09-30MNPRMonopar TherapeuticsM Exercise/Conversion—
2021-06-30MNPRMonopar Therapeutics · Restricted Stock UnitsM Exercise/Conversion—
2021-06-30MNPRMonopar TherapeuticsM Exercise/Conversion—
2021-03-31MNPRMonopar Therapeutics · Restricted Stock UnitsM Exercise/Conversion—
2021-03-31MNPRMonopar TherapeuticsM Exercise/Conversion—
2021-01-26MNPRMonopar Therapeutics · Stock OptionsA Award—
2021-01-26MNPRMonopar Therapeutics · Restricted Stock UnitsA Award—
2020-12-31MNPRMonopar Therapeutics · Restricted Stock UnitsM Exercise/Conversion—
2020-12-31MNPRMonopar TherapeuticsM Exercise/Conversion—
2020-09-30MNPRMonopar Therapeutics · Restricted Stock UnitsM Exercise/Conversion—
2020-09-30MNPRMonopar TherapeuticsM Exercise/Conversion—
2020-06-30MNPRMonopar Therapeutics · Restricted Stock UnitsM Exercise/Conversion—
2020-06-30MNPRMonopar TherapeuticsM Exercise/Conversion—
2020-03-31MNPRMonopar TherapeuticsM Exercise/Conversion—
2020-03-31MNPRMonopar Therapeutics · Restricted Stock UnitsM Exercise/Conversion—
2020-01-31MNPRMonopar Therapeutics · Stock OptionsA Award—
2020-01-31MNPRMonopar Therapeutics · Restricted Stock UnitsA Award—

Recent filings

9